Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation
opened article
Volum 11, Issue 4
December 2024
Cover Image

Article contents

opened journal
Volum 11, Issue 4
December 2024
Cover Image

Abstract

Introduction

The Coronavirus Disease 2019 (COVID-19) pandemic presented a significant challenge for global society, leaving a profound impact across the board. Although COVID-19 cases are still reported, they are no longer at previously high levels. One of the key tools in combating the pandemic was Artificial Intelligence (AI), which played a vital and advancing role throughout the pandemic. AI contributed significantly to the gradual reduction in COVID-19 cases. Effective coordination of the pandemic response, timely management, and the integration of AI into the medical system were crucial factors in achieving success.

Materials and methods

A comprehensive literature review focusing on publications from 2019 to 2024 was conducted using Google Scholar, PubMed, and Science Direct. Twenty publications were selected for their relevance to AI in the COVID-19 response, based on criteria such as accessibility, language, and publication type.

Results

The review focused on the significant role of AI during the COVID-19 pandemic, highlighting its impact on public health and medical systems. In countries like the USA, China, and South Korea, AI was crucial in tracking the virus, predicting infection trends, and optimizing resource allocation. AI models helped identify outbreak hotspots and enabled targeted interventions, while natural language processing efficiently managed extensive data. Conversely, in countries such as Brazil, Mexico, India, and many African nations, AI was used less extensively due to limitations in technological infrastructure and data availability. The pandemic drove a closer integration of AI with medical services, streamlining processes and saving time. AI also enhanced laboratory efficiency and supported the development of new medications and vaccines. Despite its potential, the uneven adoption highlighted disparities in technological readiness and resource allocation during the crisis.

Conclusions

The COVID-19 pandemic has once again highlighted that we live in an era of advanced technology and underscores the need for closer integration between healthcare systems and artificial intelligence. This integration allows for more effective and timely management of current and future health challenges. AI contributes to a more rapid and high-quality response to emergencies, providing innovative solutions for both existing and upcoming challenges.

Key Messages

What is not yet known on the issue addressed in the submitted manuscript

AI’s role in pandemic response is acknowledged; however, there is limited data on its effectiveness across various countries and its capacity to address technological disparities. This lack of data makes it unclear how AI’s benefits can be applied consistently in regions with different levels of technological infrastructure. 

The research hypothesis

AI significantly improves pandemic management by optimizing resource allocation, predicting infection trends, and enhancing diagnostics, though its effectiveness is influenced by regional technological capabilities and data availability. 

The novelty added by the manuscript to the already published scientific literature 

Research results underscore the advancement of AI technologies during the pandemic and their potential for future public health crises, addressing gaps in understanding AI’s role in pandemic preparedness and response.

Introduction

Throughout the 21st century, numerous breakthroughs in the field of Artificial Intelligence (AI) have significantly improved our lives. With the onset of Coronavirus Disease 2019 (COVID-19), which has caused approximately 6.9 million deaths globally since its emergence in December 2019, according to the World Health Organization (WHO) [1], these technological advancements have become indispensable tools for managing and coordinating the pandemic response. COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had profound impacts on public health, economies, and daily life worldwide [2].

The rapid spread of COVID-19 necessitated innovative solutions for monitoring,  predicting, and controlling the outbreak. AI technologies have been pivotal in predicting infection trends, optimizing resource allocation, facilitating drug discovery, and enhancing diagnostic capabilities. For instance, machine learning algorithms have been used to forecast outbreak hotspots, while natural language processing tools have managed the overwhelming amount of data generated during the pandemic [3].

The integration of AI into the COVID-19 response has provided critical support across many fields, highlighting its potential to enhance pandemic management and prepare for future public health emergencies. Despite various challenges and controversies surrounding AI use, recent literature demonstrates the effectiveness of different AI systems in managing COVID-19. For example, these algorithms can assist doctors in designing personalized treatment plans, leading to faster patient recovery. Furthermore, AI's applications extend beyond COVID-19 management, offering improvements in handling other diseases, including non-communicable ones, and enhancing the accuracy, efficiency, and speed of medical systems [4].

This study explores the effective integration of AI into the coordination and leadership of medical systems, highlighting the advancements achieved during the COVID-19 pandemic. It illustrates how AI contributes to a more efficient medical system, not only in the context of COVID-19 but also in preparing for future medical crises.

Materials and methods

This study conducted a thorough review of existing literature using a range of key resources. Initially, Google Scholar was utilized, followed by academic databases such as PubMed and ScienceDirect (Elsevier), which were pivotal for the search.

The search strategy employed keywords including "Artificial Intelligence," "COVID-19 response," "Pandemic management," and "Machine learning". Only publications from the years 2019 to 2024 were considered, resulting in approximately 297 articles.

Articles that were not freely accessible, unavailable through the Scientific Medical Library of the Nicolae Testemițanu State University of Medicine and Pharmacy (SUMPh), duplicates, or inaccessible in Moldova were excluded. The remaining articles were then refined using advanced search filters to focus exclusively on English-language publications with full text, systematic reviews, and meta-analyses. This process ensured the inclusion of highly relevant and high-quality sources.

From the filtered articles, 20 studies were selected based on their relevance to the application of artificial intelligence in coordinating the COVID-19 response. These studies were meticulously analyzed to evaluate their contributions and insights into how AI technologies were employed during the pandemic.

Results

AI use in COVID-19 management. During the COVID-19 pandemic, countries like the United States of America (USA), China, and South Korea extensively used AI for tracking the virus, predicting infection trends, optimizing resources, and enhancing diagnostics. AI models forecasted outbreak hotspots, enabling targeted interventions, while natural language processing managed vast amounts of data, improving information extraction. Conversely, countries such as Brazil, Mexico, India, and many African nations used AI to a lesser extent or not at all. This disparity is due to differences in technological infrastructure, data availability, and governmental support [5, 6].

Initial limitations of AI. While AI provided significant support, it is important to note that it was not fullyprepared for such a global health crisis initially. Until the end of 2020, AI was not fully utilized for tracking and predicting COVID-19 cases due to the lack of large amounts of historical data necessary for training AI models. Consequently, early studies published shortly after the global COVID-19 outbreak reported results of limited relevance, primarily due to insufficient data for adequately training AI techniques and the poor quality of the available data [7].

Preparation for future pandemics. It is surprising that the world had already received a stark warning about the need for better pandemic preparedness. In 2015, in the wake of the Ebola epidemic, Bill Gates, through the Gates Foundation, emphasized the critical need for global warning and response mechanisms to more effectively prepare for future pandemics. However, this call to action went largely unheeded. It seems that the Ebola crisis, despite its severity, was not enough to galvanize global action. The world required an even more catastrophic event–the COVID-19 pandemic–to fully grasp the importance of AI and advanced technological preparedness in managing global health crises [8].

AI evolution and impact. The rapid spread of COVID-19 meant that sufficient data and extensive labeled datasets were initially unavailable. Training models on unrepresentative datasets led to poor and misleading results, as the fast-evolving nature of the problem made it difficult to make informed model and parameter selections. This significantly affected the performance and accuracy of prediction models. However, today, the availability of COVID-19 surveillance data, such as daily and cumulative numbers of cases, deaths, and recoveries, is no longer an issue. In fact, years after the COVID-19 outbreak, multiple collections of detailed data are available from different sources, such as those gathered by the Johns Hopkins University Coronavirus Resource Center. These data are essential for improving the accuracy and performance of AI models, highlighting the crucial importance of AI in pandemic management [7].

Machine Learning (ML), a subfield of AI, was extensively used during the COVID-19 pandemic. ML involves developing algorithms that allow computers to learn and make predictions or decisions based on data. Initially, existing AI-based facial recognition software and cameras were used to identify individuals who were not adhering to self-isolation or quarantine guidelines. Over time, these technologies evolved, leading to the creation of new systems capable of independently identifying individuals wearing masks versus those who were not and determining whether social distancing guidelines of one meter were being followed. Similar computer vision systems were developed for hospitals to monitor interactions with bedridden COVID-19 patients, document the healthcare workers who entered the rooms, and track the duration and proximity of these interactions [9].

AI was utilized on a broad scale at various levels and proved valuable for decision makers. ML was employed to help decision-makers understand adherence to non-pharmaceutical interventions in near real-time. While AI usage was prevalent in developed and some developing countries, the high costs associated with these systems were not necessarily a barrier. Some system creators allowed the release of the complete code stack and system design, enabling others to quickly replicate and improve the systems. This approach was particularly beneficial in resource-limited settings and low- to middle-income countries. These opportunities were available from the early stages of the pandemic, indicating that the primary reasons for not using AI were not necessarily due to prohibitive costs but rather other regional or territorial factors [9, 10].

Challenges and solutions. Despite AI's potential to protect vulnerable communities in low-income countries by providing timely access to care, addressing structural and systemic barriers to AI implementation is a necessary step in these settings. This is especially critical as global efforts are made to prevent the reemergence of COVID-19 and its variants [11, 12]. 

As mentioned, AI played a leading role in coordinating COVID-19 responses; however, the previously  discussed systems alone are insufficient for successful pandemic management. While AI automated tasks that would have been impossible to manage manually in a short time, it is important to recognize that AI systems in healthcare were implemented to support decision-making processes. There remains a gap in developing data analysis and AI methods for better healthcare supply chain management. These supply chains were disrupted at an incredible speed during the pandemic, creating numerous bottlenecks. It is essential to address these issues when operating in rapidly changing environments. This is particularly true for inventory planning in healthcare supply chains, which significantly impacted healthcare services during the pandemic [13, 14].

An exemplary case of effective management is represented by Swedish Health Services, a healthcare organization in the USA, which developed a platform for healthcare workers to report real-time data on COVID-19 patient volumes, personal protective equipment, staffing, ventilator usage, and other resource information. This data was shared among its hospitals to monitor unit status, allocate healthcare resources, and increase hospital bed capacity [15, 16].

In the fight against the COVID-19 pandemic, the rapid development of vaccines has been astonishing, due in part to AI. Numerous research laboratories continuously worked to create vaccines and medications against COVID-19 during the pandemic. AI was employed to evaluate existing drug compounds and determine their efficacy in combating the coronavirus. Countries such as South Korea and the United States utilized AI-based systems to discover repurposed drugs with potential for treating COVID-19 [17, 18].

Although the pandemic has caused global stagnation, it has paradoxically accelerated modernization and advancements in healthcare. Future plans include the enhanced automation of medical systems, primarily aimed at protecting and facilitating human work. For example, several types of robots have been developed to meet specific needs. Cylindrical robots are designed to move through hospital corridors, assisting healthcare workers by checking the temperature, blood pressure, and oxygen saturation of COVID-19 patients on ventilators. Another type of robot, designed to move vertically, disinfects hospital interiors using UV rays. Some remote-controlled drones transport infectious samples to external laboratories for testing. Currently, research laboratories and medical companies are developing remote-controlled robots capable of collecting blood samples and oral swabs for COVID-19 testing without human contact. Additionally, in various hospitals and nursing homes, robots are used to interact with patients, maintaining a safe distance. Although a range of robots is already in use, future plans include expanding automation in the medical system, which is expected to play a crucial role in pandemic coordination [19, 20].

Discussion

The COVID-19 pandemic showcased the transformative potential of AI in enhancing public health management. This study highlights AI’s crucial role in predicting infection trends, optimizing healthcare resource allocation, and supporting real-time decision-making. By integrating AI technologies, public health systems were able to respond more swiftly, improve patient outcomes, and reduce strain on healthcare resources.

An additional example of AI’s application is the UK Government’s Bluetooth-based app, which alerted the non-infected population about potential exposure to high-risk areas or COVID-positive individuals. This tool demonstrated AI's value in infection prevention, but it also revealed challenges, such as data privacy concerns and the need for improved technological infrastructure in certain regions [17].

Ultimately, the study underscores the importance of expanding AI’s use in future health crises, addressing gaps in technology access, and ensuring ethical governance for broader and more equitable implementation.

Conclusions

The extensive use of AI during the COVID-19 pandemic significantly facilitated more efficient and rapid coordination of the response. AI technology helped avoid mass errors in database management and prevented additional cases of illness among healthcare workers. The implementation of AI proved to be a valuable asset, particularly by enabling robust management of the pandemic and preventing larger-scale crises.

Competing interests

None declared.

Authors’ contributions

DD contributed significantly to the conception and design of the review, the analysis and interpretation of the literature, as well as drafting and revising the manuscript. OL actively participated in the literature search, critically reviewed the scientific content, and provided essential contributions to the final conclusions.

Acknowledgements and funding

No external funding.

Authors’ ORCID IDs:

Daniela Demișcanhttps://orcid.org/0009-0000-4551-2606

Oleg Lozan – https://orcid.org/0000-0002-1552-1496

References

  1. World Health Organization. Coronavirus Disease (COVID-19) Dashboard [Internet]. Geneva: WHO; 2023 [cited 2024 Jul 18]. Available from: https://covid19.who.int/

  2. Centers for Disease Control and Prevention. About COVID-19 [Internet]. Atlanta: CDC; 2020 [cited 2024 Jul 21]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19.ht…

  3. Lv C, Guo W, Yin X, Liu L, Huang X, Li S, Zhang L. Innovative applications of artificial intelligence during the COVID-19 pandemic. Infect Med. 2024;3(1):100095. doi: 10.1016/j.imj.2024.100095.

  4. Das S, Ayus I, Gupta D. A comprehensive review of COVID-19 detection using machine learning and deep learning techniques. Health Technol. 2023;13:679-92. doi: 10.1007/s12553-023-00757-z.

  5. Arora N, Banerjee AK, Narasu ML. The role of artificial intelligence in tackling COVID-19. Future Virol. 2020;15(11):717-724. doi: 10.2217/fvl-2020-0130.

  6. Farhat F, Sohail SS, Alam MT, Ubaid S, Shakil A, Ashhad M, Madsen DØ. COVID-19 and beyond: leveraging artificial intelligence for enhanced outbreak control. Front Artif Intell. 2023 Nov 8;6:1266560. doi: 10.3389/frai.2023.1266560. 

  7. Comito C, Pizzuti C. Artificial intelligence for forecasting and diagnosing COVID-19 pandemic: a focused review. Artif Intell Med. 2022 Jun;128:102286. doi: 10.1016/j.artmed.2022.102286. 

  8. Piccialli F, di Cola V, Giampaolo F, et al. The role of artificial intelligence in fighting the COVID-19 pandemic. Inf Syst Front. 2021;23:1467-97. doi: 10.1007/s10796-021-10131-x.

  9. Syrowatka A, Kuznetsova M, Alsubai A, et al. Leveraging artificial intelligence for pandemic preparedness and response: a scoping review to identify key use cases. NPJ Digit Med. 2021;4(1):96. doi: 10.1038/s41746-021-00459-8.

  10. Zhang L, Wang C, Li R, et al. An interactive COVID-19 mobility impact and social distancing analysis platform [preprint]. 2020 [cited 2024 Jul 21]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.29.20085472v1

  11. Alami H, Rivard L, Lehoux P, et al. Artificial intelligence in health care: laying the foundation for responsible, sustainable, and inclusive innovation in low- and middle-income countries. Global Health. 2020;16(1):52. doi: 10.1186/s12992-020-00584-1.

  12. Burnazovic E, Yee A, Levy J, Gore G, Rahimi SA. Application of artificial intelligence in COVID-19-related geriatric care: a scoping review. Arch Gerontol Geriatr. 2024;116:105129. doi: 10.1016/j.archger.2023.105129.

  13. Raj A, Mukherjee AA, de Sousa Jabbour AB, Srivastava SK. Supply chain management during and post-COVID-19 pandemic: mitigation strategies and practical lessons learned. J Bus Res. 2022;142:1125-39. doi: 10.1016/j.jbusres.2022.01.037.

  14. Ortiz-Barrios M, Arias-Fonseca S, Ishizaka A, Barbati M, Avendaño-Collante B, Navarro-Jiménez E. Artificial intelligence and discrete-event simulation for capacity management of intensive care units during the COVID-19 pandemic: a case study. J Bus Res. 2023;160:113806. doi: 10.1016/j.jbusres.2023.113806.

  15. Drees J. Swedish health services tap Microsoft to build app that tracks COVID-19 patients and hospital capacity. 2020 Apr 2 [cited 2024 Jul 22]. In: Becker's Hospital Review [Internet]. Chicago: Becker's Healthcare; c2024- Available from: https://www.beckershospitalreview.com/healthcare-information-technology…

  16. Whitelaw S, Mamas MA, Topol E, Van Spall HGC. Applications of digital technology in COVID-19 pandemic planning and response. Lancet Digit Health. 2020 Aug;2(8):e435-e440. doi: 10.1016/S2589-7500(20)30142-4. Erratum in: Lancet Digit Health. 2021 Mar;3(3):e147. doi: 10.1016/S2589-7500(21)00016-9. 

  17. Kühl N, Martin D, Wolff C, Volkamer M. „Healthy surveillance”: designing a concept for privacy-preserving mask recognition AI in the age of pandemics. In: Proceedings of the 54th Hawaii International Conference on System Sciences; 2021 Jan 4-8. Honolulu; 2021. p. 1706-1715. doi: 10.24251/HICSS.2021.206.

  18. Liu J, Cheng WH, Nahrstedt K, Jain R, Ricci E, Byun H, et al. Coping with pandemics: opportunities and challenges for AI multimedia in the "New Normal". In: MM '20: Proceedings of the 28th ACM International Conference on Multimedia; 2020 Oct 12-16; Seattle. New York: ACM; 2020. p. 4794-4795. doi: 10.1145/3394171.3424910.

  19. Kovach CR, Taneli Y, Neiman T, Dyer EM, Arzaga AJ, Kelber ST. Evaluation of an ultraviolet room disinfection protocol to decrease nursing home microbial burden, infection and hospitalization rates. BMC Infect Dis. 2017;17(1):186. doi: 10.1186/s12879-017-2275-2.

  20. Ashique S, Mishra N, Mohanto S, Garg A, Taghizadeh-Hesary F, Gowda BHJ, Chellappan DK. Application of artificial intelligence (AI) to control COVID-19 pandemic: Current status and future prospects. Heliyon. 2024;10(4):e25754. doi: 10.1016/j.heliyon.2024.e25754.

More articles

Research Monoclonal antibodies to human kappa and lambda light chains suitable for staining of formalin-fixed, paraffin-embedded tissue
Sergei I. Syrbu1, Michael B. Cohen2
https://doi.org/10.52645/MJHS.2024.4.01
The hallmark of most B-cell neoplasia is proliferation of B-cells and clonal rearrangement of the immunoglobulin gene, which is lambda or kappa light chain restricted. Since fresh tissue is not always available to determine clonality, immunohistochemical (IHC) staining for kappa and lambda light chains is often performed on formalin-fixed, paraffin-embedded (FFPE) tissue. Commercially available polyclonal antibodies typically produce high background staining and have a significant false negative rate, which makes it difficult to prove clonality. We developed a series of monoclonal antibodies to human kappa and lambda light chain constant regions by immunizing mice with purified kappa and lambda immunoglobulin light chains.
Research Impact of umbilical cord pathology on perinatal outcomes: risk factors and clinical implications
Iurie Dondiuc*, Alina Alsatou, Hristiana Capros
https://doi.org/10.52645/MJHS.2024.4.02
Umbilical cord pathology can contribute to neonatal asphyxia, stillbirth, and postnatal death in numerous cases. However, the diagnosis of umbilical cord pathology remains imperfect, and its impact on pregnancy course and outcome is often underestimated. Therefore, prenatal diagnosis of umbilical cord pathology is becoming increasingly important in preventing intra- and postnatal morbidity and mortality. Early detection of these abnormalities enables the development of necessary strategies for optimal pregnancy and delivery management
Research Development and validation of a questionnaire for hygienic estimation of the impact of risk factors on morbidity due to osteoporosis
Victoria Bologan1*, Lucia Mazur-Nicorici2, Larisa Spinei3, Serghei Cebanu1, Anatolie Visnevschi4, Elena Ciobanu1
https://doi.org/10.52645/MJHS.2024.4.03
Osteoporosis remains a major public health issue, particularly affecting the elderly, and is characterized by decreased bone mass and deterioration of bone structure, increasing the risk of severe fractures. The development of specific and precise tools that allow for the identification and estimation of the influence of modifiable factors on the development of osteoporosis is an important step in early intervention for at-risk individuals
Research Disability-adjusted life years associated with liver-related complications among patients with Delta viral infection in Republic of Moldova
Ecaterina Cebanu1*, Adela Turcanu1,2, Octavian Sajin3
https://doi.org/10.52645/MJHS.2024.4.04
Disability-adjusted life years (DALY) is a multidimensional measure used to quantify specific tasks of the disease. Chronic liver disease attributed to hepatitis Delta virus (HDV) is one of the major causes that contribute to morbidity and mortality in our country. The DALY estimate in HDV-induced liver disease has the potential to highlight both fatal and nonfatal outcomes of the disease and thus, help in policy making and allocation of health resources
Research The importance of mucogingival flaps in guided bone regeneration in the jaws
Vasile Zugrav*, Dumitru Chele, Nicolae Chele, Ghenadie Cucu
https://doi.org/10.52645/MJHS.2024.4.05
Guided bone regeneration (GBR) is a surgical method that allows the formation of new bone in areas of atrophy of the maxillary bone. The integration of the graft or the augmented bone under the mucosal flap and the primary healing of the soft tissues are essential conditions for preventing the exposure of the regeneration site and infectious complications that inevitably lead to the failure of the GBR procedure
Research Analysis of spironolactone in compound powder by ultraviolet-visible spectrophotometry
Spironolactone (Spir) is a selective and competitive antagonist of aldosterone that increases the excretion of water and sodium while decreasing the excretion of potassium (K+ sparing diuretic). The substance was studied to develop qualitative and quantitative methods of analysis and to validate them according to documents regulating the quality of active pharmaceutical ingredients in the development of pharmaceutical forms
Case study A case report of primary hepatic amyloidosis manifesting as severe cholestasis and acute liver failure
Eugen Tcaciuc1, Elina Berliba1, Kalina Bugor2, Ruslan Pretula3, Cătălina Olaru-Stăvilă1*, Ana Maria Bădărău1
https://doi.org/10.52645/MJHS.2024.4.10
Hepatic amyloidosis is characterized by the deposition of fibrillar amyloid proteins, which result from light chain amyloidosis (AL) immunoglobulin fragments, in the extracellular space and the vessel walls of the liver. A case of primary hepatic amyloidosis without evidence of a primary or secondary cause of amyloid deposition is rare. This case was unique to the Republic of Moldova, presenting a diagnostic and therapeutic challenge for clinicians. Because the liver is rarely affected, this pathology remains underdiagnosed and is associated with a reserved prognosis.
Case study Unusual presentation of MALT lymphoma. A case report
Eugen Tcaciuc1, Cătălina Olaru-Stăvilă1*, Angela Tcaciuc2, Lilian Antoci3, Mircea Cernat3, Margareta Surlari4
https://doi.org/10.52645/MJHS.2024.4.11
MALT lymphoma is the most common type of extranodal non-Hodgkin lymphoma. In two-thirds of cases, it originates in the stomach and is strongly associated with Helicobacter pylori infection. It presents a complex clinical picture, that can resemble multiple conditions, and typically follows a benign course